2. Cigna Corp. has entered seven outcomes-based deals since 2009, according to the report. Danish drugmaker Novo Nordisk recently signed its first pay-for-performance contract with Humana for the diabetes treatment Victoza. Novartis, Merck & Co., Amgen, Sanofi and Eli Lilly & Co., have also signed similar contracts with various insurers in the past year, according to the report.